Clinical Trials Browser

OTHER × Photons × 30 days × Clear all

NCT06508463 2026-03-16

Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

Phase 1 Recruiting

Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic

NCT03996850 2026-03-13

SPECT/CT for the Characterization of Renal Masses

Active not recruiting

Kidney Neoplasms

NCT04857502 2026-03-13

99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

Phase EARLY_PHASE1 Recruiting

Prostatic Neoplasms

NCT06288113 2026-03-13

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

Phase 2 Recruiting

Prostatic Neoplasms

NCT05010109 2026-03-11

Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation

Phase NA Recruiting

Lung Neoplasms

NCT03028311 2026-03-10

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

Phase 1 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06216249 2026-03-10

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Phase 2 Recruiting

Prostatic Neoplasms

NCT06408116 2026-03-10

PEGASUS

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT03561220 2026-03-09

COMPPARE

Phase NA Active not recruiting

Prostatic Neoplasms

NCT04083937 2026-03-09

PAROS

Phase NA Recruiting

Prostatic Neoplasms

NCT05237453 2026-03-09

PUMA

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06526299 2026-02-20

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Phase 2 Recruiting

Prostatic Neoplasms